Literature DB >> 11669560

Response of metastatic epidermoid anal cancer to single agent irinotecan: a case report.

F Grifaichi1, A Padovani, F Romeo, C Trinca, L Moscetti, E Cortesi.   

Abstract

We report a case of a patient affected by epidermoid anal cancer who had hepatic progression after standard therapy with the Nigro regimen (fluorouracil and mitomycin C plus radiotherapy). This is an uncommon neoplasm against which only few chemotherapeutic agents have been tested. In our patient salvage treatment with low dose irinotecan resulted in a partial response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11669560     DOI: 10.1177/030089160108700113

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Hellenic society of medical oncology (HESMO) guidelines for the management of anal cancer.

Authors:  Nikolaos Gouvas; Sophia Gourtsoyianni; Maria Angeliki Kalogeridi; John Sougklakos; Louisa Vini; Evangelos Xynos
Journal:  Updates Surg       Date:  2020-11-24

2.  A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal.

Authors:  Diana V Golub; A Cahid Civelek; Vivek R Sharma
Journal:  Chemother Res Pract       Date:  2011-06-15

3.  Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?

Authors:  Alice Dewdney; Sheela Rao
Journal:  ISRN Oncol       Date:  2012-05-06

4.  Management of two cases of recurrent anal carcinoma.

Authors:  Eiko Klimant; Maurie Markman
Journal:  Case Rep Oncol       Date:  2013-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.